Peer Coaching Intervention in Young Adults With Congenital Heart Disease (CHASM in ACHD)

June 1, 2026 updated by: Duke University

Peer Coaching Adaptive Self-Management Interventions for Young Adults With Congenital Heart Disease

The purpose of the study is to evaluate a peer coaching intervention in young adults with congenital heart disease.

Study Overview

Status

Active, not recruiting

Intervention / Treatment

Detailed Description

Our research team has developed a peer coaching intervention that has been deployed to promote activated self-management for AYAs with several conditions, and this has been modified adolescents and young adults (AYA) with with congenital heart disease (CHD). This study will be conducted over two years and pair AYA with CHD with a peer coach who also has CHD has successfully navigated the transition to adult medical care and over six months will work to promote the motivation for self-care as well as the development of self-management skills. This pilot study will test feasibility and acceptability, as well as preliminary efficacy and long-term effects on successful transfer to adult cardiology.

Study Type

Interventional

Enrollment (Actual)

33

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • North Carolina
      • Durham, North Carolina, United States, 27710
        • Duke Health

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 26 years (Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Age 18-26
  • Diagnosis of congenital heart disease
  • Patient at a Duke pediatric cardiology clinic
  • Access to a smart phone

Exclusion Criteria:

  • Cognitive delay
  • Patient at an adult cardiology clinic

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Peer Coaching
Participant receive a 6 month peer health coaching intervention.
The Peer Coaching group will receive 6 months of peer health coaching via a secure telephone and text messaging system.
No Intervention: Education only
Participants receive education-only material (newsletter) biweekly for 6 months

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Evaluate number of participants enrolled
Time Frame: Up to 2 months after recruitment closes
Evaluate the number of participants contacted about the study who actually enrolled
Up to 2 months after recruitment closes
Evaluate completion of study
Time Frame: Up to 8 months after enrollment of each participant
Determine the number of participants who enrolled in the study who completed it
Up to 8 months after enrollment of each participant
Measure impact on health
Time Frame: Up to 8 months after enrollment of each participant
Evaluate the number of participant who stated the intervention had a positive impact on their health
Up to 8 months after enrollment of each participant
Determine change in patient activation
Time Frame: baseline, 3 months, 6 months
Determine change in patient activation as measured by changes over time on the Patient Activation Measure (PAM)
baseline, 3 months, 6 months
Determine change in self-management
Time Frame: baseline, 3 months, 6 months
Determine change in self-management as measured by changes over time in the Partners in health Scale (PIH)
baseline, 3 months, 6 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Determine change in transition readiness
Time Frame: baseline, 3 months, 6 months
Determine the change in transition readiness over 6 months as measured by the Transition Readiness Assessment Questionaire (TRAQ)
baseline, 3 months, 6 months
Determine change in health related quality of life
Time Frame: baseline, 3 months, 6 months
Determine the change in health related quality of life over 6 months as measured by the Short-From 12 (SF-12)
baseline, 3 months, 6 months
Determine change in emotional health
Time Frame: baseline, 3 months, 6 months
Determine the change in emotional health over 6 months as measured by the Brief Symptom Inventory (BSI)
baseline, 3 months, 6 months
Evaluate successful transfer of participants from pediatric to adult cardiology care
Time Frame: up to 10 years
Evaluate number of participants that transfer from pediatric to adult cardiology care with at least consecutive visits 10 years post study
up to 10 years

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Principal Investigator: Richard A Krasuski, MD, Duke University
  • Principal Investigator: Gary Maslow, MD, MPH, Duke University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 8, 2020

Primary Completion (Actual)

January 18, 2023

Study Completion (Estimated)

March 2, 2032

Study Registration Dates

First Submitted

February 13, 2020

First Submitted That Met QC Criteria

February 13, 2020

First Posted (Actual)

February 17, 2020

Study Record Updates

Last Update Posted (Actual)

June 2, 2026

Last Update Submitted That Met QC Criteria

June 1, 2026

Last Verified

June 1, 2026

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Congenital Heart Disease

Clinical Trials on Peer Health Coaching

Subscribe